Alternatives to tretinoin
2 same-class SPL records vs tretinoin - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Retin-A
About tretinoin
Tretinoin capsules help put acute promyelocytic leukemia (APL) into remission. You can use this medicine if other treatments have not worked or cannot be used.
Used for: Tretinoin capsules treat acute promyelocytic leukemia (APL) in adults and children at least 1 year old. APL is a type of cancer where there is a problem with certain blood cells. This medicine is for people whose APL has not responded to other treatments or for whom other treatments are not an option.
2 Retinoid (Topical) peers (wide set)
tretinoin vs adapalene & tazarotene · FAERS reaction fields
FAERS top-reaction field "Rash" shows the widest count spread between tretinoin and adapalene, tazarotene in this extract (15,133-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | tretinoin | adapalene | tazarotene |
|---|---|---|---|
| Pain | 536 | - | 64 |
| Vomiting | 463 | - | - |
| Nausea | 423 | - | 32 |
| Rash | 387 | 15,520 | 62 |
| Headache | 377 | - | 55 |
| Diarrhoea | 361 | - | 32 |
| Paraesthesia | 356 | - | - |
| Fatigue | 336 | - | 32 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
tretinoin peer mix vs class inventory
Peer mix
1 OTC and 1 Rx SPL records in this peer set (2 total). Class inventory for Retinoid (Topical): 3 drugs.
Frequently Asked Questions
How many OTC vs Rx SPL records sit beside tretinoin? ▼
Reading a wide Retinoid (Topical) peer set (2 records)
tretinoin (Retin-A) sits in a wide Retinoid (Topical) peer set (2 of 2 class peers shown). Labeled indication field for tretinoin: Tretinoin capsules treat acute promyelocytic leukemia (APL) in adults and children at least 1 year old.
Top FAERS reaction fields for tretinoin total 3,899 reports across 10 reactions, set beside adapalene, tazarotene. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for tretinoin: see also the generic vs brand label guide when reading Retin-A SPL strings.
Read our methodology - how this data is sourced, computed, and verified.